REOLYSIN Trademark

Trademark Overview

On Monday, December 6, 1999, a trademark application was filed for REOLYSIN with the United States Patent and Trademark Office. The USPTO has given the REOLYSIN trademark a serial number of 75864483. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 15, 2024. This trademark is owned by ONCOLYTICS BIOTECH INC.. The REOLYSIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for use in the treatment of Cancer
reolysin

General Information

Serial Number75864483
Word MarkREOLYSIN
Filing DateMonday, December 6, 1999
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 15, 2024
Registration Number2837573
Registration DateTuesday, May 4, 2004
Mark Drawing1 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 1, 2003

Trademark Statements

Goods and ServicesPharmaceuticals for use in the treatment of Cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 15, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameONCOLYTICS BIOTECH INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCalgary, Alberta T2N 1X7
CA
Party NameONCOLYTICS BIOTECH INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCalgary, Alberta T2N 1X7
CA
Party NameONCOLYTICS BIOTECH INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCalgary, Alberta T2N 1X7
CA

Trademark Events

Event DateEvent Description
Thursday, May 4, 2000LETTER OF SUSPENSION MAILED
Friday, April 28, 2000ASSIGNED TO EXAMINER
Monday, June 19, 2000UNRESPONSIVE/DUPLICATE PAPER RECEIVED
Monday, December 4, 2000CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 23, 2003APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 11, 2003NOTICE OF PUBLICATION
Tuesday, July 1, 2003PUBLISHED FOR OPPOSITION
Tuesday, September 23, 2003NOA MAILED - SOU REQUIRED FROM APPLICANT
Monday, April 9, 2001INQUIRY AS TO SUSPENSION MAILED
Thursday, September 26, 2002LETTER OF SUSPENSION MAILED
Wednesday, March 26, 2003FAX RECEIVED
Wednesday, March 26, 2003CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 4, 2004REGISTERED-PRINCIPAL REGISTER
Tuesday, May 29, 2007CASE FILE IN TICRS
Thursday, May 28, 2009TEAS SECTION 8 & 15 RECEIVED
Wednesday, June 3, 2009ASSIGNED TO PARALEGAL
Monday, February 22, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 26, 2011TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 26, 2011ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 29, 2014TEAS SECTION 8 & 9 RECEIVED
Thursday, October 16, 2003FAX RECEIVED
Thursday, October 16, 2003Sec. 1(B) CLAIM DELETED
Thursday, March 18, 2004NOTICE OF ALLOWANCE CANCELLED
Tuesday, June 9, 2009REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, February 13, 2014CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, February 13, 2014NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, May 4, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, November 15, 2024CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Thursday, February 13, 2014REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Wednesday, January 29, 2014REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
Thursday, February 13, 2014REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

Related Keywords

reolysin cancer treatment pharmaceuticals